Læknablaðið - 15.03.2009, Page 52

Nýjar og einfaldari pakkningastærðir
4 vikna
upphafspakki
CHAMWX o,5mg
CHflMPlX w
... MflVERTBOKNE TABLETT v reniclin
SÍSEV —
Uge/Vika/Uke 1
J)
Uge/Vika/Uke 2
^ J)
U9e/Vika/Uke 3
« v U9e/Wk^ke4
lr -f I *
8
O O9
I J 5 K
TABLETTER,
& ®11
4|i OT
(***«

0.5 ">9
12
híetab^
"* 25

, iMri

ld **

nimov0ftfu'cne
m »‘)14
i
.*>

»i*r-
, >
ssssss---:

CHAMWX
m.»ŒS5r»«'
SSSSS&. >

8 vikna
framhalds-
meðferð
Heimildir:
1. Gonzales D et al. Varenicline, an á4á2 nicotinic acethylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking
cessation. A randomized controlled trial. JAMA 2006; 296(1):47-55
2. Jorenby DE et al. Efficacy of varenicline, an á4á2 nicotinic acethylcholine receptor partial agonist, vs sustained-release bupropion and placebo for
smoking cessation. A randomized controlled trial. JAMA 2006; 296(1 ):56-63
3. Tonstad S et al. Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial. JAMA 2006; 296(1 ):64-71
4. Aubin H et al. Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised, open-label trial. Thorax online,
February 8th 2008. Downloaded from thorax.bmj.com on 19. February 2008.
*Byggt á MNWS (Minnesota Nicotine Withdrawal Scale), stuttur spurningalisti um löngun í að reykja og aðlagaður spurningalisti um reykingar.